Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 3/20 | 0.35 |
| ▸ | MMP3 | P08254 | 3/20 | 0.35 |
| ▸ | MMP9 | P14780 | 3/20 | 0.35 |
| ▸ | MMP13 | P45452 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12723280 | 0.80 | ALDH1A1 (0.35) | GAAMAPTALDH1A1LMNA | |
| SCHEMBL5593871 | 0.79 | ALDH1A1 (0.33) | MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL12723249 | 0.78 | MEN1 (0.41) | MEN1KMT2ATERTMAPTNPC1 | |
| SCHEMBL9319280 | 0.77 | ALDH1A1 (0.41) | GAAMAPTALDH1A1LMNA | |
| SCHEMBL1632771 | 0.75 | ALDH1A1 (0.42) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL1633688 | 0.75 | BCHE (0.39) | GAAMAPTALDH1A1LMNA | |
| SCHEMBL1634269 | 0.75 | ALDH1A1 (0.39) | GAAMAPTNPC1ALDH1A1RAB9A | |
| SCHEMBL1776316 | 0.74 | ALDH1A1 (0.46) | MEN1KMT2ATERTMAPTNPC1 | |
| SCHEMBL1632904 | 0.72 | PLK1 (0.46) | GAAMEN1KMT2ATERTMAPT | |
| Ammonia Solution, Strong SCHEMBL3027164 | 0.71 | GAA (0.56) | AOC3GAAMMP2MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932393-B2 | Insecticidal (heteroarylalky)alkane thio and oxo amine derivatives | FMC CORPORATION (US) | 2011-04-26 | — | — | US | disclosed |
| US-20100261757-A1 | Insecticidal (Heteroarylalky)alkane Thio and Oxo Amine Derivatives | FMC CORPORATION | 2010-10-14 | — | — | US | disclosed |
| WO-2007085356-A2 | INSECTICIDAL (HETEROARYLALKYL)ALKANE THIO AND OXO AMINE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261757-A1 | Insecticidal (Heteroarylalky)alkane Thio and Oxo Amine Derivatives | DDT, AKR7A2, TAAR1 | AOC3 246/4885GAA 3395/4885MEN1 4602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.